A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients

NCT04550897 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class

Stopped After interim-analysis: No signals of clinical or immunological efficacy detected, and decision was made not to continue the trial.

Conditions

Interventions

Sponsor

Oslo University Hospital